Login / Signup

SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein.

Andrew D ChesneyBuddhadev MaitiUlrich H E Hansmann
Published in: The Journal of chemical physics (2023)
Parkinson's disease is accompanied by the presence of amyloids in the brain that are formed of α-synuclein chains. The correlation between COVID-19 and the onset of Parkinson's disease led to the idea that amyloidogenic segments in SARS-COV-2 proteins can induce aggregation of α-synuclein. Using molecular dynamic simulations, we show that the fragment FKNIDGYFKI of the spike protein, which is unique for SARS-COV-2, preferentially shifts the ensemble of α-synuclein monomer toward rod-like fibril seeding conformations and, at the same time, differentially stabilizes this polymorph over the competing twister-like structure. Our results are compared with earlier work relying on a different protein fragment that is not specific for SARS-COV-2.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • protein protein
  • binding protein
  • multiple sclerosis
  • machine learning
  • blood brain barrier
  • subarachnoid hemorrhage
  • molecularly imprinted
  • monte carlo